Companies: 10,795·Total market cap: $144.5T
Applied DNA Sciences, Inc.

Applied DNA Sciences, Inc.

APDNNASDAQHealthcare
$5.62
+$1.35(+31.62%)
Market Cap$7257454
P/E Ratio
52W High$319.95
52W Low$2.13

Applied DNA Sciences, Inc.(APDN)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · APDN · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-092024-092023-092022-092021-09
Revenue
Revenue$2.14M$3.43M$13.37M$18.17M$9.03M
Cost of Revenue$1.30M$2.41M$7.83M$13.12M$4.10M
Gross Profit$0.84M$1.02M$5.53M$5.05M$4.93M
Gross Margin %(computed)39.26%29.63%41.39%27.82%54.59%
Operating Expenses
R&D Expenses$6.02M$3.59M$3.74M$3.93M$3.77M
G&A Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
Total Operating Expenses$16.89M$15.04M$16.49M$19.02M$17.22M
Operating Income($16.05M)($14.02M)($10.95M)($13.97M)($12.29M)
Operating Margin %(computed)-750.92%-408.72%-81.94%-76.89%-136.16%
Interest Income$0.19M$0.18M$0.08M$0.01M$0.01M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($15.64M)($7.09M)($10.02M)($8.27M)($14.28M)
Income Tax Expense$0.68M$0.00M$0.00M$0.00M$0.00M
Net Income($69.49M)($6.99M)($9.95M)($8.38M)($16.03M)
Net Margin %(computed)-203.78%-74.41%-46.11%-177.56%
Per Share & EBITDA
EPS (Basic)$-134.23$-1.82$-15.21$-18.68$-46.35
Wtd Avg Shares0.52M3.97M0.65M0.45M0.35M
EBITDA($16.05M)($13.33M)($9.59M)($12.68M)($11.68M)
EBITDA Margin %(computed)-750.92%-388.42%-71.75%-69.79%-129.41%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Applied DNA Sciences, Inc.

关于Applied DNA Sciences, Inc.(APDN)损益表

Applied DNA Sciences, Inc.(APDN)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,APDN实现营收$0.00B,毛利润$0.00B(毛利率39.26%),净利润($0.07B)(净利率-3251.74%)。

常见问题

APDN · 4 问

Applied DNA Sciences, Inc.(APDN)2025财年营收为$0.00B,同比down37.7%。

APDN revenueAPDN salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09